Search results for nkx2-2

101 hits were found for nkx2-2

# Family MCID Name MIFTS Score
1
EWN003 Ewing Sarcoma 70 15.477
2
P MTR004 Maturity-Onset Diabetes of the Young 68 14.667
3
P NNT058 Neonatal Diabetes 52 14.240
4
P OLG002 Oligodendroglioma 66 13.274
5
P MCK013 Meckel Syndrome, Type 1 64 11.488
6
P PRM030 Permanent Neonatal Diabetes Mellitus 59 9.472
7
ASK001 Askin's Tumor 32 8.123
8
CHN056 Chondrosarcoma, Extraskeletal Myxoid 42 8.123
9
P PNC045 Pancreatic Agenesis 43 8.123
10
P HLP001 Holoprosencephaly 69 8.123
11
SPN035 Spindle Cell Sarcoma 54 3.989
12
SRC014 Sarcoma 65 3.989
13
P LYM118 Lymphoma 67 3.734
14
HLX001 Helix Syndrome 48 3.355
15
SRC027 Sarcoma, Synovial 58 2.820
16
LYM133 Lymphoma, Hodgkin, Classic 74 2.640
17
NDL021 Nodular Lymphocyte Predominant Hodgkin Lymphoma 41 2.543
18
c NRB015 Neuroblastoma 2 29 2.543
19
P NRB001 Neuroblastoma 66 2.543
20
CLR017 Clear Cell Sarcoma 44 2.543
21
MYP002 Myoepithelial Carcinoma 46 2.543
22
MYP001 Myoepithelioma 37 2.543
23
DSM007 Desmoplastic Small Round Cell Tumor 54 2.543
24
OST159 Osteogenic Sarcoma 66 2.441
25
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 2.331
26
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 2.331
27
c BDY005 Body Mass Index Quantitative Trait Locus 9 47 2.331
28
c BDY012 Body Mass Index Quantitative Trait Locus 7 44 2.331
29
P BDY004 Body Mass Index Quantitative Trait Locus 11 83 2.331
30
c BDY006 Body Mass Index Quantitative Trait Locus 8 44 2.331
31
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 2.331
32
NLX003 Neu-Laxova Syndrome 2 46 2.331
33
c BDY020 Body Mass Index Quantitative Trait Locus 19 52 2.331
34
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 2.331
35
c BDY019 Body Mass Index Quantitative Trait Locus 18 47 2.331
36
P GLM040 Glioma Susceptibility 1 71 1.786
37
GLM045 Glioma 63 1.786
38
P PNC035 Pancreatic Cancer 86 1.199
39
P RRT020 Rare Tumor 39 1.035
40
c SCH079 Schizophrenia 1 44 1.035
41
P RHB003 Rhabdomyosarcoma 66 1.035
42
SML003 Small Cell Osteogenic Sarcoma 25 1.035
43
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 45 0.845
44
CRV035 Cervical Cancer 73 0.845
45
DFF005 Diffuse Large B-Cell Lymphoma 54 0.845
46
P LKM062 Leukemia, Acute Lymphoblastic 69 0.845
47
P PRS040 Prostate Cancer 95 0.845
48
P BCL017 B-Cell Lymphoma 59 0.845
49
CRV002 Cervix Uteri Carcinoma in Situ 47 0.845
50
TCL027 T-Cell Acute Lymphoblastic Leukemia 51 0.845
51
MNG006 Monogenic Diabetes 44 0.845
52
CRV045 Cervical Intraepithelial Neoplasia 39 0.845
53
P BRS047 Breast Cancer 98 0.602
54
MTC005 Mitochondrial Metabolism Disease 45 0.597
55
ACT238 Acth Deficiency, Isolated 52 0.597
56
P OST002 Osteoporosis 76 0.597
57
PLY150 Polykaryocytosis Inducer 29 0.597
58
P MLT020 Multiple Sclerosis 79 0.597
59
AGN018 Agenesis of Corpus Callosum, Cardiac, Ocular, and Genital Syndrome 57 0.597
60
MRG003 Marginal Zone B-Cell Lymphoma 52 0.597
61
SPL004 Splenic Marginal Zone Lymphoma 50 0.597
62
MNT001 Mantle Cell Lymphoma 67 0.597
63
c BNM022 Bone Mineral Density Quantitative Trait Locus 8 45 0.597
64
P BNM029 Bone Mineral Density Quantitative Trait Locus 15 48 0.597
65
c ATS007 Autism Spectrum Disorder 72 0.597
66
KLD003 Keloid Formation 34 0.597
67
PTT046 Pituitary Hormone Deficiency, Combined, 2 62 0.597
68
c HYP326 Hyperinsulinemic Hypoglycemia, Familial, 5 51 0.597
69
c HYP271 Hyperinsulinemic Hypoglycemia, Familial, 4 53 0.597
70
CHL065 Cholangiocarcinoma 58 0.597
71
P FLL037 Follicular Lymphoma 74 0.597
72
P HYP083 Hypopituitarism 52 0.597
73
HYP066 Hyperglycemia 61 0.597
74
GLB002 Glioblastoma 67 0.597
75
P ADN016 Adenocarcinoma 63 0.597
76
INT079 Intrahepatic Cholangiocarcinoma 51 0.597
77
TCL028 T-Cell Lymphoblastic Leukemia/lymphoma 46 0.597
78
P TRT010 Teratoma 51 0.597
79
NRL005 Neurilemmoma 60 0.597
80
HYP060 Hyperinsulinism 54 0.597
81
KLD004 Keloid Disorder 39 0.597
82
HYP056 Hypoglycemia 65 0.597
83
c LKM005 Leukemia, T-Cell, Chronic 34 0.597
84
FBR019 Fibromatosis 42 0.597
85
NRL016 Neural Tube Defects 81 0.470
86
IRN008 Iron Overload in Africa 51 0.400
87
c CHL136 Cholestasis, Progressive Familial Intrahepatic, 2 57 0.400
88
HPT079 Hepatoid Adenocarcinoma 39 0.400
89
NNL005 Non-Alcoholic Fatty Liver Disease 63 0.400
90
RJS001 Ruijs-Aalfs Syndrome 47 0.400
91
c HPT073 Hepatitis C Virus 71 0.400
92
PLM173 Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and 46,xx Sex Reversal 34 0.400
93
P HPT023 Hepatocellular Carcinoma 96 0.400
94
PDT042 Pediatric Hepatocellular Carcinoma 49 0.400
95
SKN022 Skin Squamous Cell Carcinoma 54 0.400
96
c PRG047 Progressive Familial Intrahepatic Cholestasis 64 0.400
97
ADL096 Adult Hepatocellular Carcinoma 60 0.400
98
FBR086 Fibrolamellar Carcinoma 59 0.400
99
HPT011 Hepatocellular Clear Cell Carcinoma 46 0.400
100
PSD011 Pseudovascular Skin Squamous Cell Carcinoma 16 0.400
101
PTY007 Pityriasis Rotunda 26 0.400
Content
Loading form....